The National Oncologic PET Registry (NOPR) Working Group submitted a formal request to the Centers for Medicare and Medicaid Services (CMS), asking that it end the prospective data collection requirements under Coverage with Evidence Development (CED) for use of NaF-18 PET (CAG-00065R) imaging in intended patient management. CMS has initiated its review of this request. Read more.
At this time, CMS is soliciting comments on the NOPR’s request. The public comment period will be open for 30 days, until April 16, 2015. PET facilities participating in the NOPR are encouraged to provide comments (which can be entered directly on-line on the CMS web site at the link below). Additionally, we encourage PET facilities to ask referring physicians who frequently use NaF-18 PET in the care of their patients to submit comments to CMS indicating how NaF-18 PET has helped with patient management. Comments that cite scientific evidence (including unpublished data) including the full range of uses of NaF-18 PET in oncology and the uses of NaF-18 PET in benign bone and joint diseases will be particularly valuable to CMS. Submit comments.